Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study

被引:0
作者
Madhawa Neranjan Gunathilake
Jeonghee Lee
Il Ju Choi
Young-Il Kim
Yongju Ahn
Chanhyeok Park
Jeongseon Kim
机构
[1] Graduate School of Cancer Science and Policy,Department of Cancer Control and Population Health
[2] Graduate School of Cancer Science and Policy,Department of Cancer Biomedical Science
[3] National Cancer Center,Center for Gastric Cancer, National Cancer Center Hospital
[4] Microbiome Division,undefined
[5] Theragen Etex,undefined
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The human gut hosts a diverse community of bacteria referred to as the gut microbiome. We investigated the association between the relative abundance of gastric microbiota and gastric cancer (GC) risk in a Korean population. The study participants included 268 GC patients and 288 controls. DNA was extracted from gastric biopsies, and 16S rRNA gene analysis was performed. Unconditional logistic regression models were used to observe the associations. Of the participants, those who had the highest level (highest tertile) of relative Helicobacter pylori and Propionibacterium acnes abundances showed a significantly higher risk for GC after adjusting for potential confounding variables (odds ratio (OR) = 1.86, 95% confidence interval (CI) = 1.17–2.97, p for trend = 0.017 and OR = 4.77, 95% CI = 2.94–7.74, p for trend <0.001, respectively). Subjects who carried Prevotella copri had a significantly higher risk of GC than noncarriers (OR = 2.54, 95% CI = 1.42–4.55, p for trend = 0.002). There was a lower risk of GC in subjects carrying Lactococcus lactis than in noncarriers (OR = 0.21, 95% CI = 0.10–0.44, p for trend <0.001). H. pylori, P. acnes and P. copri are strong risk factors, whereas L. lactis is a protective factor, for GC development in Koreans. Further microbiome studies are warranted to verify the findings of the current study.
引用
收藏
相关论文
共 81 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 68 394-424
  • [2] Jung K-W(2018)Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015 Cancer Res Treat. 50 303-22
  • [3] Won Y-J(2018)Prediction of Cancer Incidence and Mortality in Korea, 2018 Cancer Res Treat. 50 317-86
  • [4] Kong H-J(2016)Analysis and Interpretation of the Human Microbiome Inflamm Bowel Dis. 22 1713-36
  • [5] Lee ES(2015)Cancer and the microbiota Science. 348 80-236
  • [6] Jung K-W(2017)Introduction to the human gut microbiota Biochem J. 474 1823-90
  • [7] Won Y-J(2018)Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota Gut. 67 226-1600
  • [8] Kong H-J(2017)The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer PLoS Pathogens. 13 e1006573-6
  • [9] Lee ES(2011)Global cancer statistics CA Cancer J Clin. 61 69-416
  • [10] Ashton JJ(2009)Second asia–pacific consensus guidelines for helicobacter pylori infection J Gastroenterol Hepatol. 24 1587-936